Opendata, web and dolomites


A disruptive, life-saving solution for home monitoring and management of lung fluid congestion in heart failure patients

Total Cost €


EC-Contrib. €






Project "ReDS" data sheet

The following table provides information about the project.


Organization address
address: MEIR ARIEL 6
postcode: 4059300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2019-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Heart failure (HF) is one of the main causes of mortality and hospitalization worldwide, affecting around 26M people globally, and the most common cause of hospitalization for people over 65. Lung fluid congestion is one of the main HF-related clinical conditions, which leads to a vicious cycle of repeated hospitalizations of HF patients. Strikingly, 1 in 4 patients are readmitted to the hospital within 30 days, and 1 in 2 patients within 6 months. The key challenge is to enable early detection, continuous monitoring and timely treatment of symptoms before the patient undergoes respiratory distress. In fact, current lung fluid monitoring practices are mostly inaccurate and inefficient, enabling detection only at very advanced stages, when symptoms cannot be prevented by simply changing the medication.

Sensible introduces ReDS™, a non-invasive home monitoring system for lung fluid congestion in HF patients. The monitoring procedure can be performed by the patient at home in just 90 seconds. The results are processed by an Artificial Intelligence (AI)-driven patient management platform and sent automatically to the physician. The unique proprietary AI algorithm supports physicians in identifying the best treatment based on each patients’ needs and general health status. ReDS™ is the first solution that enables accurate, remote monitoring and management of fluid congestion in HF patients after discharge.

During the phase 1 feasibility study, Sensible will define a minimum viable product, establish a sound go-to-market strategy and supply chain, and draft further development plans. During the second phase of the innovation project, Sensible will optimize the device engineering for home use, optimize the AI algorithm, scale-up device manufacturing and perform clinical validation with partner hospitals.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More